| Age, yrs |
62.3 ± 11.2 |
| Male |
8890 (68.3%) |
| Body mass index, kg/m2
|
24.7 ± 3.4 |
| Current smoker |
4097 (31.5%) |
| Medical history |
|
| Previous stroke/Transient ischaemic attack |
3122 (24.0%) |
| Coronary artery disease |
1315 (10.1%) |
| Previous myocardial infarction |
215 (1.7%) |
| Hypertension |
8167 (62.8%) |
| Diabetes mellitus |
2964 (22.8%) |
| Dyslipidemia |
1024 (7.9%) |
| Atrial fibrillation |
856 (6.6%) |
| Peripheral artery disease |
98 (0.8%) |
| Modified Rankin Scale at admission |
2 (1−3)*
|
| National Institutes of Health Stroke Scale at admission |
3 (1−6)*
|
| Index event |
|
| Transient ischaemic attack |
832 (6.4%) |
| Ischaemic stroke |
12,180 (93.6%) |
| In-hospital medication |
|
| Antiplatelet therapy within 48 h |
12,570 (97.3%) |
| Lipid-lowering agent |
12,494 (96.7%) |
| Antihypertensive agent |
6040 (46.8%) |
| Anticoagulants |
1308 (10.1%) |
| Stroke etiology-TOAST classification |
|
| Large artery atherosclerosis |
3431 (26.4%) |
| Cardioembolism |
768 (5.9%) |
| Small vessel occlusion |
2968 (22.8%) |
| Other determined cause |
174 (1.3%) |
| Undetermined pathogenesis |
5671 (43.6%) |
| Essen score |
2 (1−3)*
|
| 0−2 |
8889 (68.3%) |
| 3−6 |
4116 (31.6%) |
| 7−9 |
7 (0.05%) |
